Skip to content

13F-HR filed by Prescott General Partners LLC

Prescott General Partners LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 10 holding rows worth $1,262,181,866.

Accession
0001104659-23-060728
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 10 entries on the cover page, a total value of $1,262,181,866 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,262,181,866 with VALUE read as dollars as filed, 13F file number 028-14951. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CREDIT ACCEP CORP MICH225310101COM1,560,014$680,228,505dollars as filed
CIMPRESS PLCG2143T103SHS EURO3,906,492$171,182,479dollars as filed
WORLD ACCEP CORPORATION981419104COM2,037,495$169,702,959dollars as filed
WAYFAIR INC94419L101CL A3,823,239$131,290,027dollars as filed
YELP INC CL A985817105Stock1,975,197$60,638,548dollars as filed
GLOBAL INDUSTRIAL COMPANY COM37892E102Stock1,128,821$30,297,556dollars as filed
GRINDR INC39854F101COM2,280,604$14,185,357dollars as filed
LINEAGE CELL THERAPEUTICS IN53566P109COMMON STOCK1,851,851$2,777,777dollars as filed
HUMACYTE INC44486Q103COM568,246$1,755,880dollars as filed
AGEX THERAPEUTICS INC00848H108COM185,185$122,778dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-060728this filing2023-05-15acceptance time not in the bulk data set